Controversies and Misconceptions in Malaria Chemoprophylaxis for Travelers

Lin H. Chen(Mount Auburn Hospital), Patricia Schlagenhauf(World Health Organization - Pakistan), Mary Wilson(University of California System)

JAMA

May 23, 2007

10.1001/jama.297.20.2251

Cited by 122

Related Papers

Covid-19 and community mitigation strategies in a pandemic

|BMJ|2020|584

Going global – Travel and the 2019 novel coronavirus

|Travel Medicine and Infectious Disease|2020|376

Chikungunya and dengue autochthonous cases in Europe, 2007–2012

|Travel Medicine and Infectious Disease|2013|255

Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation

|The Lancet Infectious Diseases|2014|248

Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study

|BMJ|2003|243